Excessive protein levels due to gene amplification or increased-transcription are the most common EGFR perturbations found in gastrointestinal and lung adenocarcinoma as well as in cholangiocarcinoma (Birkman et al., 2016; Jung et al., 2017; Li et al., 2008). Here, EGFR is linked to cholangiocarcinoma.